» Articles » PMID: 26817835

Comparison of Body Mass Index (BMI) with the CUN-BAE Body Adiposity Estimator in the Prediction of Hypertension and Type 2 Diabetes

Abstract

Background: Obesity is a world-wide epidemic whose prevalence is underestimated by BMI measurements, but CUN-BAE (Clínica Universidad de Navarra - Body Adiposity Estimator) estimates the percentage of body fat (BF) while incorporating information on sex and age, thus giving a better match. Our aim is to compare the BMI and CUN-BAE in determining the population attributable fraction (AFp) for obesity as a cause of chronic diseases.

Methods: We calculated the Pearson correlation coefficient between BMI and CUN-BAE, the Kappa index and the internal validity of the BMI. The risks of arterial hypertension (AHT) and diabetes mellitus (DM) and the AFp for obesity were assessed using both the BMI and CUN-BAE.

Results: 3888 white subjects were investigated. The overall correlation between BMI and CUN-BAE was R(2) = 0.48, which improved when sex and age were taken into account (R(2) > 0.90). The Kappa coefficient for diagnosis of obesity was low (28.7 %). The AFp was 50 % higher for DM and double for AHT when CUN-BAE was used.

Conclusions: The overall correlation between BMI and CUN-BAE was not good. The AFp of obesity for AHT and DM may be underestimated if assessed using the BMI, as may the prevalence of obesity when estimated from the percentage of BF.

Citing Articles

Somatization and Body Composition: Findings from a Cross-Sectional Study on Non-Clinical Young Adults.

Baranauskas M, Kupciunaite I, Lieponiene J, Stukas R Healthcare (Basel). 2025; 13(3).

PMID: 39942492 PMC: 11816891. DOI: 10.3390/healthcare13030304.


The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective.

Wang C, Huang X, He S, Kuang M, Xie G, Sheng G Lipids Health Dis. 2024; 23(1):311.

PMID: 39334354 PMC: 11438085. DOI: 10.1186/s12944-024-02299-3.


Association of the CUN-BAE body adiposity estimator and other obesity indicators with cardiometabolic multimorbidity: a cross-sectional study.

Chen X, Geng S, Shi Z, Ding J, Li H, Su D Sci Rep. 2024; 14(1):10557.

PMID: 38719889 PMC: 11078937. DOI: 10.1038/s41598-024-52164-7.


Assessing body mass index stages, individual diabetes and hypertension history effects on the risk of developing hypertension among Ghanaians: A cross-sectional study.

Iddrisu A, Adam M Health Sci Rep. 2023; 6(10):e1650.

PMID: 37900089 PMC: 10600335. DOI: 10.1002/hsr2.1650.


Association of the Clínica Universidad de Navarra-Body Adiposity Estimator With Type 2 Diabetes: A Retrospective Cohort Study.

Geng S, Chen X, Bai K, Ding J, Li H, Shi S Int J Public Health. 2023; 68:1606063.

PMID: 37810434 PMC: 10551821. DOI: 10.3389/ijph.2023.1606063.


References
1.
Dervaux N, Wubuli M, Megnien J, Chironi G, Simon A . Comparative associations of adiposity measures with cardiometabolic risk burden in asymptomatic subjects. Atherosclerosis. 2008; 201(2):413-7. DOI: 10.1016/j.atherosclerosis.2007.11.032. View

2.
Salas-Salvado J, Rubio M, Barbany M, Moreno B . [SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria]. Med Clin (Barc). 2007; 128(5):184-96. DOI: 10.1016/s0025-7753(07)72531-9. View

3.
Gallagher D, Visser M, Sepulveda D, Pierson R, Harris T, Heymsfield S . How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?. Am J Epidemiol. 1996; 143(3):228-39. DOI: 10.1093/oxfordjournals.aje.a008733. View

4.
Llorca J . [Population attributable fraction: estimation and interpretation]. Gac Sanit. 2001; 15(1):61-7. DOI: 10.1016/s0213-9111(01)71519-1. View

5.
Romero-Corral A, Somers V, Sierra-Johnson J, Thomas R, Collazo-Clavell M, Korinek J . Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008; 32(6):959-66. PMC: 2877506. DOI: 10.1038/ijo.2008.11. View